11 results
·
8ms
·
Sources: EU EUDAMED, US FDA
EPG-0176-18
Certificate
MDD Annex II Section 4·OPKO HEALTH SPAIN S.L.U.·ISTITUTO SUPERIORE DI SANITA'·2 Basic UDI-DIs
EPG-0177-18
Certificate
MDD Annex II Section 4·OPKO HEALTH SPAIN S.L.U.·ISTITUTO SUPERIORE DI SANITA'·1 Basic UDI-DI
QCT-0103-08
Certificate
MDD Annex II (excluding section 4)·OPKO HEALTH SPAIN S.L.U.·ISTITUTO SUPERIORE DI SANITA'·1 Basic UDI-DI
Vis Activ Uso Continuo
Device
EU MDD
·
Eu Md Class 2a
·OPKO HEALTH SPAIN S.L.U.·On the market·1 country
Vis Glyc Neo
Device
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·On the market·1 country
Vis Glyc Monodosis
Device
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·On the market·1 country
Vis Glyc Neo
Device
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·On the market·1 country
Vis Activ Uso Continuo
Basic UDI-DI
EU MDD
·
Eu Md Class 2a
·OPKO HEALTH SPAIN S.L.U.·1 device
Vis Glyc Neo
Basic UDI-DI
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·1 device
Vis Glyc Monodosis
Basic UDI-DI
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·1 device
Vis Glyc Neo
Basic UDI-DI
EU MDD
·
Eu Md Class 3
·OPKO HEALTH SPAIN S.L.U.·1 device